Eli Lilly (LLY) Buildings (2012 - 2024)

Eli Lilly (LLY) has reported Buildings for 13 consecutive years, with $8.8 billion the latest figure, recorded in Q4 2024.

• Buildings for Q4 2024 came in at $8.8 billion, up 6.36% year-over-year; the trailing twelve-month figure through Dec 2024 was $8.8 billion (up 6.36% YoY), and the FY2024 annual result was $8.8 billion, up 6.36% from the prior year.
• Buildings was $8.8 billion for Q4 2024 at Eli Lilly, up from $8.3 billion in the prior quarter.
• Over five years, Buildings peaked at $8.8 billion in Q4 2024 and troughed at $7.3 billion in Q4 2020.
• Average Buildings over 5 years is $8.0 billion, with a median of $7.9 billion recorded in 2022.
• Year-over-year, Buildings grew 3.58% in 2021 and gained 6.36% in 2024.
• Over 5 years, Buildings stood at $7.3 billion in 2020, then climbed by 3.58% to $7.6 billion in 2021, then climbed by 4.32% to $7.9 billion in 2022, then gained by 4.6% to $8.3 billion in 2023, then advanced by 6.36% to $8.8 billion in 2024.
• Per Business Quant data, the three most recent Buildings figures were $8.8 billion in Q4 2024, $8.3 billion in Q4 2023, and $7.9 billion in Q4 2022.